Recent Updates in HR-Positive/HER2-Negative Early Breast Cancer: A Deep Dive Into Understanding the Data and Their Implications

Will the newly reported monarchE data change your clinical practice for patients with HR+/HER- early breast cancer? Credit available for this activity expires: 1/30/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/987087?src=mkm_podcast_addon_987087